Nvidia (NVDA)
Entry: Unlock
Price target: 215.00-220.00
Second PT: Unlock
Nvidia is always on watch, but this time it’s on our “official” watchlist as the stock pulls back to its 50 day moving average. Although the company remains the most valuable in the world and many argue it has reached unsustainable levels, we still see more upside as the artificial intelligence boom continues. Nvidia plays a crucial role in the AI wave, and future projects like Nvidia’s GeForce RTX 50 Series, Project DIGITS, their personal AI supercomputer initiative, and DGX Spark platform for AI developers to accelerate AI model training and deployment are all set to grow revenue significantly higher in the coming years.
One growth engine to highlight is Nvidia’s Blackwell architecture, the company’s next generation GPU platform designed to deliver massive leaps in AI training and performance. Blackwell chips are expected to power the next wave of AI data centers, offering better performance and energy efficiency compared to the current series. Major cloud providers like Amazon, Microsoft, and Google have already placed orders for Blackwell powered systems, setting the stage for another blockbuster year of data center revenue.
Nvidia is set to finish this year with around $207 billion in revenue, but the number is expected to grow close to 40% next year to $280 billion and continue growing to as much as $350 billion by 2028. With the revenue growth comes more profits, something Nvidia has continued to blow the world away with. Despite Nvidia growing to the most valuable company in history at $4.45 trillion, the stock’s price to earnings ratio has actually decreased as it rallied higher…why? Because profits have continued to increase. The company’s efficiency leaves it at a price to earnings ratio of 51x, and while that is argued to be expensive, markets are willing to pay the premium given that earnings per share are expected to nearly triple in the next three years.
Risk:
While Nvidia’s growth outlook remains strong, there are still key risks to watch. The semiconductor industry is cyclical and can be volatile, and rising competition from alternative chip architectures could pressure pricing or market share…this is what we’ve seen recently from AMD. Export restrictions, especially involving China, pose another challenge, while producing advanced chips at scale remains complex and costly. Lastly, Nvidia is already sitting an extreme valuation, leaving limited room for error if demand slows or execution falters.
Nonetheless, the current outlook suggests Nvidia has more growth ahead. We’ll monitor any changes and adjust our outlook as needed.
Please note that this may take longer than one week to come around to targets and we may change our entry / exit levels if necessary. We'll be updating the stock as needed for our Hyper Stocks Pro members. Wanna see real-time market updates? Learn more here.
Globus Medical (GMED)
Entry: Unlock
Price target: 69.00-71.00
Second PT: Unlock
We placed Globus Medical on our watchlist back in September after the company delivered strong earnings and affirmed its full-year guidance. The stock hasn’t moved much since, but it has been building a base around the 50.00-60.00 range, signaling that selling pressure may be subdued and posting to a potential recovery.
The stock initially faced pressure due to concerns surrounding the integration of its NuVasive and Nevro acquisitions (details to follow), as well as uncertainty after the unexpected resignation of its CEO in July. However, sentiment appears to be improving as the company begins to show progress on its integration efforts. The $3.1 billion NuVasive acquisition positioned Globus as the second largest player in the spine market, an important step toward its goal of becoming the world’s leading musculoskeletal solutions provider. While the merger came with its fair share of challenges, including missed synergy targets early on, recent workforce restructuring and operational improvements suggest that Globus may finally be turning the corner and setting up for stronger execution in the months ahead.
Globus’s absorption of NuVasive and Nevro is already showing up in the numbers. In Q2 2025, the company brought in $94.6 million from Nevro’s neuromodulation products, highlighting strong cross-selling potential. Even after $64.2 million in integration costs, adjusted EBITDA rose 9.6% from last year, showing solid operational control. U.S. spine sales climbed 5.7%, and “Enabling Technologies” from NuVasive also saw a modest recovery. If their next earnings on November 6th beat expectations, they may give them the boost above this base.
Please note that this may take longer than one week to come around to targets and we may change our entry / exit levels if necessary. We'll be updating the stock as needed for our Hyper Stocks Pro members. Wanna see real-time market updates? Learn more here.
New Oriental Education & Technology Group (EDU)
Entry: Unlock
Price target: 64.00-65.00
Second PT: Unlock
Artificial intelligence is beginning to reshape education, and New Oriental Education & Technology Group is positioning itself as an early mover in the space. The Chinese based company leverages large language models and proprietary AI tools for adaptive learning, essay grading, assessment, and content creation, all aimed at driving better student outcomes and operational efficiency.
After China’s 2021 education crackdown, New Oriental successfully pivoted toward compliant, diversified offerings, including non-academic tutoring and innovation programs that cultivate creativity and well-rounded development. The company has also launched personalized learning devices, delivering adaptive content to users.
$EDU operates across 77 schools and 1,300+ learning centers in 70 cities. Its reach has powered revenue growth of 13.8% last year to nearly $5 billion, while net income rose 20% to $372 million. The balance sheet remains robust, with $7.8 billion in assets and $3.85 billion in liabilities, leaving about $4 billion in equity, impressive for a company valued at roughly $8.5 billion.
As AI starts to permeate the education landscape, New Oriental’s early investments in technology could translate into both improved learning outcomes and stronger margins, making $EDU a potential play for the adoption.
Please note that this may take longer than one week to come around to targets and we may change our entry / exit levels if necessary. We'll be updating the stock as needed for our Hyper Stocks Pro members. Wanna see real-time market updates? Learn more here.
Stock Name - Unlock
Entry target: 59.00-61.00
Price target: 72.50-75.00
Second PT: 80.00-85.00
You've reached the end of our complimentary public watchlist. Unlock for the full list by becoming a member of our Hyper Stocks community. Click here to unlock more high probability set-ups!
Stock Name - Unlock
Entry: 19.00-20.00
Price target: 26.00-27.00
Second PT: 30.00-31.00
You've reached the end of our complimentary public watchlist. Unlock for the full list by becoming a member of our Hyper Stocks community. Click here to unlock more high probability set-ups!
Stock Name - Unlock
Entry: TBD
Price target: 360.00-370.00
Second PT: 390.00-400.00
You've reached the end of our complimentary public watchlist. Unlock for the full list by becoming a member of our Hyper Stocks community. Click here to unlock more high probability set-ups!
Stock Name - Unlock
Entry: 49.00-51.00 (Pull back entry)
Price target: 58.00-60.00
Second PT: TBD
You've reached the end of our complimentary public watchlist. Unlock for the full list by becoming a member of our Hyper Stocks community. Click here to unlock more high probability set-ups!
___________________________________
The stocks posted above are the preliminary stocks and set ups we’ll be watching this week. All price points are subject to change based on market performance and sector health. Please do your own research and analysis on these companies/charts before taking on any set ups. This page and our services are for educational purposes only. This is not financial advice. Please consult with a professional for financial advice. Trade at your own risk and as always, good luck!
Disclaimer: This article is for informational and educational purposes only and does not constitute financial advice. Investing involves risk, including the possible loss of capital. Always do your own research or consult with a licensed financial advisor before making investment decisions.